• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
A one dollar bill sitting next to a declining stock graph
Favicon Fierce Pharma

Vor Bio's surprise $4B revival deal splits investor reactions

In response to the deal, Vor's stock price more than doubled in premarket trading, while RemeGen’s stock price in Hong Kong dropped 18% Thursday.
Angus Liu Jun 26, 2025 10:55am
red heart wrapped in stethoscope over EKG

Novartis pens ProFound pact for cardiovascular disease targets

Jun 26, 2025 6:30am
3D rendering of SARS-CoV-2 virus particles

Invivyd says Pemgarda sequel could be alternative to COVID shots

Jun 26, 2025 10:12am
Liver

Altimmune stock sinks on mixed ph. 2 MASH results for GLP-1 drug

Jun 26, 2025 8:41am
bird birds flying humingbirds

Hummingbird uses VISTA buzz to secure $290M pact for tumor drug

Jun 26, 2025 4:53am
proclaim red announcement

FDA amplifies Medtronic recall of Bravo acid reflux test capsule

Jun 26, 2025 10:33am
More News

Alto’s phase 2 depression trial misses primary efficacy endpoint

Jun 26, 2025 9:28am

Cosmo to connect Medtronic GI Genius with Apple Vision Pro

Jun 25, 2025 4:00pm

FDA moves to block Olympus endoscope imports

Jun 25, 2025 12:05pm

Minovia skates SPAC-wards into public market

Jun 25, 2025 10:33am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings